A citation-based method for searching scientific literature

Federica Klaus, Karoline Guetter, Rebecca Schlegel, Erich Seifritz, Anahita Rassi, Beat Thöny, Flurin Cathomas, Stefan Kaiser. Psychiatry Res 2021
Times Cited: 2







List of co-cited articles
4 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Increased random exploration in schizophrenia is associated with inflammation.
Flurin Cathomas, Federica Klaus, Karoline Guetter, Hui-Kuan Chung, Anjali Raja Beharelle, Tobias R Spiller, Rebecca Schlegel, Erich Seifritz, Matthias N Hartmann-Riemer, Philippe N Tobler,[...]. NPJ Schizophr 2021
3
100

Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia.
R S Wallwork, R Fortgang, R Hashimoto, D R Weinberger, D Dickinson. Schizophr Res 2012
388
100


Toward a more parsimonious assessment of neurocognition in schizophrenia: a 10-minute assessment tool.
Gagan Fervaha, Ofer Agid, George Foussias, Gary Remington. J Psychiatr Res 2014
19
100

The blood-brain barrier in psychosis.
Thomas A Pollak, Svetlana Drndarski, James M Stone, Anthony S David, Philip McGuire, N Joan Abbott. Lancet Psychiatry 2018
81
50

The brief negative symptom scale: psychometric properties.
Brian Kirkpatrick, Gregory P Strauss, Linh Nguyen, Bernard A Fischer, David G Daniel, Angel Cienfuegos, Stephen R Marder. Schizophr Bull 2011
352
50

3-Hydroxykynurenine: an intriguing molecule exerting dual actions in the central nervous system.
Ana Laura Colín-González, Perla D Maldonado, Abel Santamaría. Neurotoxicology 2013
52
50

Relationship of neurocognitive deficits to diagnosis and symptoms across affective and non-affective psychoses.
Kathryn E Lewandowski, Bruce M Cohen, Matcheri S Keshavan, Dost Ongür. Schizophr Res 2011
58
50

The brief negative symptom scale: validation of the German translation and convergent validity with self-rated anhedonia and observer-rated apathy.
Martin Bischof, Caitriona Obermann, Matthias N Hartmann, Oliver M Hager, Matthias Kirschner, Agne Kluge, Gregory P Strauss, Stefan Kaiser. BMC Psychiatry 2016
25
50



Quinolinic Acid, an endogenous molecule combining excitotoxicity, oxidative stress and other toxic mechanisms.
Verónica Pérez-De La Cruz, Paul Carrillo-Mora, Abel Santamaría. Int J Tryptophan Res 2012
92
50

The kynurenine pathway in schizophrenia and bipolar disorder.
Sophie Erhardt, Lilly Schwieler, Sophie Imbeault, Göran Engberg. Neuropharmacology 2017
104
50

The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies.
Wolfgang Marx, Amelia J McGuinness, Tetyana Rocks, Anu Ruusunen, Jasmine Cleminson, Adam J Walker, Susana Gomes-da-Costa, Melissa Lane, Marsal Sanches, Alexandre P Diaz,[...]. Mol Psychiatry 2020
14
50

Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials.
Yu Hayasaka, Marianna Purgato, Laura R Magni, Yusuke Ogawa, Nozomi Takeshima, Andrea Cipriani, Corrado Barbui, Stefan Leucht, Toshi A Furukawa. J Affect Disord 2015
135
50

Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
Timothy B Meier, Wayne C Drevets, Brent E Wurfel, Bart N Ford, Harvey M Morris, Teresa A Victor, Jerzy Bodurka, T Kent Teague, Robert Dantzer, Jonathan Savitz. Brain Behav Immun 2016
76
50

Cognitive profiles in persons with depressive disorder and Alzheimer's disease.
Claudia Lanza, Karolina Sejunaite, Charlotte Steindel, Ingo Scholz, Matthias W Riepe. Brain Commun 2020
1
100

Acute effects of cigarette smoke on inflammation and oxidative stress: a review.
H van der Vaart, D S Postma, W Timens, N H T ten Hacken. Thorax 2004
428
50

Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis.
Eric Plitman, Yusuke Iwata, Fernando Caravaggio, Shinichiro Nakajima, Jun Ku Chung, Philip Gerretsen, Julia Kim, Hiroyoshi Takeuchi, M Mallar Chakravarty, Gary Remington,[...]. Schizophr Bull 2017
81
50

Validation of the Personal and Social Performance (PSP) Scale in a German sample of acutely ill patients with schizophrenia.
Georg Juckel, Daniela Schaub, Nina Fuchs, Ute Naumann, Idun Uhl, Henning Witthaus, Ludger Hargarter, Hans-Werner Bierhoff, Martin Brüne. Schizophr Res 2008
65
50

Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients.
Lilly Schwieler, Martin Samuelsson, Mark A Frye, Maria Bhat, Ina Schuppe-Koistinen, Oscar Jungholm, Anette G Johansson, Mikael Landén, Carl M Sellgren, Sophie Erhardt. J Neuroinflammation 2016
36
50

Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia.
J K Yao, G G Dougherty, R D Reddy, M S Keshavan, D M Montrose, W R Matson, S Rozen, R R Krishnan, J McEvoy, R Kaddurah-Daouk. Mol Psychiatry 2010
65
50

Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.
J C O'Connor, M A Lawson, C André, M Moreau, J Lestage, N Castanon, K W Kelley, R Dantzer. Mol Psychiatry 2009
730
50

Metabolic dysfunctions in the kynurenine pathway, noradrenergic and purine metabolism in schizophrenia and bipolar disorders.
Nils Eiel Steen, Ingrid Dieset, Sigrun Hope, Trude S J Vedal, Olav B Smeland, Wayne Matson, Rima Kaddurah-Daouk, Ingrid Agartz, Ingrid Melle, Srdjan Djurovic,[...]. Psychol Med 2020
3
50

The Lille Apathy Rating Scale (LARS): exploring its psychometric properties in schizophrenia.
Hanan Yazbek, Joanna Norton, Delphine Capdevielle, Aurore Larue, Jean-Philippe Boulenger, Marie-Christine Gély-Nargeot, Stéphane Raffard. Schizophr Res 2014
17
50

Reduced microglial immunoreactivity for endogenous NMDA receptor agonist quinolinic acid in the hippocampus of schizophrenia patients.
Tomasz Gos, Aye-Mu Myint, Kolja Schiltz, Gabriela Meyer-Lotz, Henrik Dobrowolny, Stefan Busse, Ulf J Müller, Christian Mawrin, Hans-Gert Bernstein, Bernhard Bogerts,[...]. Brain Behav Immun 2014
23
50

Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression.
Ebrahim Haroon, James R Welle, Bobbi J Woolwine, David R Goldsmith, Wendy Baer, Trusharth Patel, Jennifer C Felger, Andrew H Miller. Neuropsychopharmacology 2020
32
50


Serum kynurenic acid is reduced in affective psychosis.
B E Wurfel, W C Drevets, S A Bliss, J R McMillin, H Suzuki, B N Ford, H M Morris, T K Teague, R Dantzer, J B Savitz. Transl Psychiatry 2017
41
50

Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior.
Jason C O'Connor, Marcus A Lawson, Caroline André, Eileen M Briley, Sandra S Szegedi, Jacques Lestage, Nathalie Castanon, Miles Herkenham, Robert Dantzer, Keith W Kelley. J Immunol 2009
196
50

Neuroscience of apathy and anhedonia: a transdiagnostic approach.
Masud Husain, Jonathan P Roiser. Nat Rev Neurosci 2018
110
50

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).
Ronald C Kessler, Patricia Berglund, Olga Demler, Robert Jin, Doreen Koretz, Kathleen R Merikangas, A John Rush, Ellen E Walters, Philip S Wang. JAMA 2003
50

Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression.
Kymberly D Young, Wayne C Drevets, Robert Dantzer, T Kent Teague, Jerzy Bodurka, Jonathan Savitz. Brain Behav Immun 2016
34
50

Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression.
Jie Huang, Roy H Perlis, Phil H Lee, A John Rush, Maurizio Fava, Gary S Sachs, Jeffrey Lieberman, Steven P Hamilton, Patrick Sullivan, Pamela Sklar,[...]. Am J Psychiatry 2010
138
50


The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.
Keith H Nuechterlein, Michael F Green, Robert S Kern, Lyle E Baade, Deanna M Barch, Jonathan D Cohen, Susan Essock, Wayne S Fenton, Frederick J Frese, James M Gold,[...]. Am J Psychiatry 2008
50

Indoleamine 2,3 dioxygenase and metabolic control of immune responses.
David H Munn, Andrew L Mellor. Trends Immunol 2013
569
50

Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease.
Robert Schwarcz, Paolo Guidetti, Korrapati V Sathyasaikumar, Paul J Muchowski. Prog Neurobiol 2010
115
50


Shared and dissociable features of apathy and reward system dysfunction in bipolar I disorder and schizophrenia.
Matthias Kirschner, Flurin Cathomas, Andrei Manoliu, Benedikt Habermeyer, Joe J Simon, Erich Seifritz, Philippe N Tobler, Stefan Kaiser. Psychol Med 2020
6
50

Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study.
Jun-Xi Pan, Jin-Jun Xia, Feng-Li Deng, Wei-Wei Liang, Jing Wu, Bang-Min Yin, Mei-Xue Dong, Jian-Jun Chen, Fei Ye, Hai-Yang Wang,[...]. Transl Psychiatry 2018
45
50

Kynurenine pathway in depression: A systematic review and meta-analysis.
Kamiyu Ogyu, Kaoruhiko Kubo, Yoshihiro Noda, Yusuke Iwata, Sakiko Tsugawa, Yuki Omura, Masataka Wada, Ryosuke Tarumi, Eric Plitman, Sho Moriguchi,[...]. Neurosci Biobehav Rev 2018
80
50

Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients.
A M Myint, M J Schwarz, R Verkerk, H H Mueller, J Zach, S Scharpé, H W M Steinbusch, B E Leonard, Y K Kim. Brain Behav Immun 2011
70
50

Immune System and Schizophrenia.
Norbert Müller, Markus J Schwarz. Curr Immunol Rev 2010
161
50

Peripheral tryptophan, serotonin, kynurenine, and their metabolites in major depression: A case-control study.
Romain Colle, Perrine Masson, Céline Verstuyft, Bruno Fève, Erwan Werner, Claire Boursier-Neyret, Bernard Walther, Denis J David, Bruno Boniface, Bruno Falissard,[...]. Psychiatry Clin Neurosci 2020
13
50

Kynurenine pathway in major depression: evidence of impaired neuroprotection.
Aye-Mu Myint, Yong Ku Kim, Robert Verkerk, Simon Scharpé, Harry Steinbusch, Brian Leonard. J Affect Disord 2007
354
50

Apathy in late-life depression: common, persistent, and disabling.
Genevieve S Yuen, Saumya Bhutani, Bryony J Lucas, Faith M Gunning, Bassem AbdelMalak, Joanna K Seirup, Sibel A Klimstra, George S Alexopoulos. Am J Geriatr Psychiatry 2015
40
50

Examination of the validity of the Brief Neurocognitive Assessment (BNA) for schizophrenia.
Gagan Fervaha, Christina Hill, Ofer Agid, Hiroyoshi Takeuchi, George Foussias, Ishraq Siddiqui, Robert S Kern, Gary Remington. Schizophr Res 2015
16
50

Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder.
Yanling Zhou, Wei Zheng, Weijian Liu, Chengyu Wang, Yanni Zhan, Hanqiu Li, Lijian Chen, Yuping Ning. Psychoneuroendocrinology 2019
19
50

The kynurenine pathway: a finger in every pie.
Jonathan Savitz. Mol Psychiatry 2020
100
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.